feed,title,long_url,short_url
Benzinga,Astellas Takes $540M Impairment Charge Of $3B Audentes BuyÂ­out On Gene Therapy Trial Hold,https://benzinga.com/general/biotech/21/04/20820168/astellas-takes-540m-impairment-charge-of-3b-audentes-buy-out-on-gene-therapy-trial-hold,https://j.mp/3nomlrq
